Which eye implant best tames glaucoma? a head-to-head trial aims to find out.

NCT ID NCT07733453

First seen Jul 29, 2026 · Last updated Aug 04, 2026 · Updated 3 times

Summary

This trial compares two surgical implants—the Baerveldt Glaucoma Implant and the Paul Glaucoma Implant—in people with glaucoma that is not well controlled by eye drops. Both devices are tiny tubes placed in the eye to drain fluid and lower pressure. The study will track which implant works better over the long term and whether one has fewer complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a surgical implant (Baerveldt or Paul glaucoma implant) that drains fluid from the eye to lower pressure
What this could lead to
If one implant proves safer or more effective, it could become the preferred option for people with hard-to-control glaucoma.
What could go wrong
This is a single trial with 150 participants, so results may not apply to everyone. Both implants carry surgical risks like infection or implant failure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Liverpool Hospital

    Sydney, New South Wales, 2170, Australia

  • Royal Victorian Eye and Ear Hospital

    Melbourne, Victoria, 3000, Australia

    Contact Email: •••••@•••••

  • Sydney Eye Hospital

    Sydney, New South Wales, 2000, Australia

  • Westmead Hospital

    Sydney, New South Wales, 2145, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.